Search results
From Proteopedia
You searched for Simard,_A.R
There is no page with the exact title "Simard,_A.R". The search results for "Simard,_A.R" are displayed below. You can create a page titled Simard,_A.R (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Simard AR (40 bytes)
1: List of pages with the keyword Simard AR - Category:Simard JR (40 bytes)
1: List of pages with the keyword Simard JR - Category:Simard, J R (42 bytes)
1: List of pages with the keyword Simard, J R - Category:Simard, D (40 bytes)
1: List of pages with the keyword Simard, D - Category:Simard D (39 bytes)
1: List of pages with the keyword Simard D - User:William J Simard (221 bytes)
1: * Full Real Name: William J. Simard
5: ...stitution (NO ABBREVIATIONS): The University of Vermont
7: * City, State/Province, Country: Burlington, Vermont, US
9: * Field of Expertise or Study: Biochemistry - Category:Simard, A.R (42 bytes)
1: List of pages with the keyword Simard, A.R
Page text matches
- 8f6v (1,586 bytes)
2: ==Crystal Structure of Nanobody VHH108 Bound to Its Antigen PA14 Cif...
3: ...aption='[[8f6v]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=8F6V FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.3Å</td></tr> - 8f6u (1,633 bytes)
2: ==Crystal Structure of Nanobody VHH113 Bound to Its Antigen PA14 Cif...
3: ...aption='[[8f6u]], [[Resolution|resolution]] 1.70Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=8F6U FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 1.7Å</td></tr> - 9oyu (409 bytes)
1: '''Unreleased structure'''
3: The entry 9oyu is ON HOLD until Paper Publication
5: ...mard, A.R., Mwaura, B.W., Bliska, J.B., Madden, D.R.
7: ...plex with the PYD domain of human pyrin (limited proteolysis)
8: [[Category: Unreleased Structures]] - 8gjr (1,757 bytes)
2: ==Crystal Structure of Nanobody VHH114 Bound to Its Antigen PA14 Cif...
3: ...aption='[[8gjr]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=8GJR FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.85Å</td></tr> - 1xuu (2,611 bytes)
2: ...(NeuB) in complex with Mn2+ and Malate from Neisseria meningitidis==
3: ...aption='[[1xuu]], [[Resolution|resolution]] 1.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1XUU FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 1.9Å</td></tr> - 1xuz (2,754 bytes)
2: ...isseria meningitidis, bound to Mn2+, Phosphoenolpyruvate, and N-acetyl mannosaminitol==
3: ...aption='[[1xuz]], [[Resolution|resolution]] 2.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1XUZ FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.2Å</td></tr> - 2qlq (6,857 bytes)
2: ...ture of SRC kinase domain with covalent inhibitor RL3==
3: ...aption='[[2qlq]], [[Resolution|resolution]] 2.33Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2QLQ FirstGlance]. <br>
6: ...-(DIMETHYLAMINO)BUT-2-ENAMIDE'>SR2</scene></td></tr> - 2qq7 (5,826 bytes)
2: ...stant SRC kinase domain with irreversible inhibitor==
3: ...aption='[[2qq7]], [[Resolution|resolution]] 2.38Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2QQ7 FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.38Å</td></tr> - 3f3t (5,329 bytes)
2: ==Kinase domain of cSrc in complex with inhibitor RL38 (Type III)==
3: ...aption='[[3f3t]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3F3T FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 3f3u (5,320 bytes)
2: ==Kinase domain of cSrc in complex with inhibitor RL37 (Type III)==
3: ...aption='[[3f3u]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3F3U FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 3f3v (5,851 bytes)
2: ==Kinase domain of cSrc in complex with inhibitor RL45 (Type II)==
3: ...aption='[[3f3v]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3F3V FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 3f3w (5,863 bytes)
2: ...tant cSrc kinase domain in complex with inhibitor RL45 (Type II)==
3: ...aption='[[3f3w]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3F3W FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 3g5d (5,889 bytes)
2: ==Kinase domain of cSrc in complex with Dasatinib==
3: ...aption='[[3g5d]], [[Resolution|resolution]] 2.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3G5D FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.2Å</td></tr> - 3gcp (10,307 bytes)
3: ...aption='[[3gcp]], [[Resolution|resolution]] 2.25Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3GCP FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.25Å</td></tr>
7: ...L)-3H-IMIDAZOL-4-YL]-PYRIDINE'>SB2</scene></td></tr> - 3gcq (10,344 bytes)
2: ==Human P38 MAP kinase in complex with RL45==
3: ...aption='[[3gcq]], [[Resolution|resolution]] 2.00Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3GCQ FirstGlance]. <br>
6: ...action, [[Resolution|Resolution]] 2Å</td></tr> - 3gcs (10,333 bytes)
2: ==Human P38 MAP kinase in complex with Sorafenib==
3: ...aption='[[3gcs]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3GCS FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 3gcu (10,424 bytes)
2: ==Human P38 MAP kinase in complex with RL48==
3: ...aption='[[3gcu]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3GCU FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 3gcv (10,346 bytes)
2: ==Human P38 MAP Kinase in Complex with RL62==
3: ...aption='[[3gcv]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3GCV FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.3Å</td></tr> - 3hub (8,162 bytes)
3: ...aption='[[3hub]], [[Resolution|resolution]] 2.25Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3HUB FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.25Å</td></tr>
7: ...dbligand=BOG:B-OCTYLGLUCOSIDE'>BOG</scene></td></tr> - 3huc (8,192 bytes)
2: ==Human p38 MAP Kinase in Complex with RL40==
3: ...aption='[[3huc]], [[Resolution|resolution]] 1.80Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3HUC FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 1.8Å</td></tr>
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)